Latest News for: neuro

Edit

Neuro Sharp Gains Recognition in 2025 as Your Ultimate Brain Enhancement Formula

Nasdaq Globe Newswire 14 Aug 2025
Scientifically Formulated Nootropic Backed by 2025 Research for Sharper Focus and Cognitive Support. Scientifically Formulated Nootropic Backed by 2025 Research for Sharper Focus and Cognitive Support ... .
Edit

ClearPoint Neuro Reports Second Quarter 2025 Results

ACCESSWIRE 13 Aug 2025
SOLANA BEACH, CA / ACCESS Newswire / August 12, 2025 / ClearPoint Neuro, Inc ... About ClearPoint Neuro. ClearPoint Neuro is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine ... CLEARPOINT NEURO, INC.
Edit

Business/Financial Results (Form 8-K) (ClearPoint Neuro Inc)

Public Technologies 12 Aug 2025
ClearPoint Neuro Reports Second Quarter 2025 Results ... SOLANA BEACH, CA, August 12, 2025 - ClearPoint Neuro, Inc ... About ClearPoint Neuro ... The Company's flagship product, the ClearPoint Neuro Navigation System, has FDA clearance and is CE-marked.
Edit

Earnings Release Q2 2025 (ClearPoint Neuro Inc)

Public Technologies 12 Aug 2025
August 12, 2025 ClearPoint Neuro Reports Second Quarter 2025 Results ... SOLANA BEACH, CA / ACCESS Newswire / August 12, 2025 / ClearPoint Neuro, Inc ... About ClearPoint Neuro ... [email protected] CLEARPOINT NEURO, INC ... ClearPoint Neuro, Inc.
Edit

Quarterly Report for Quarter Ending June 30, 2025 (Form 10-Q) (ClearPoint Neuro Inc)

Public Technologies 12 Aug 2025
In 2022, we commercialized the ClearPoint Prism Neuro Laser Therapy System as our first therapy product offering. We have exclusive global commercialization rights to the ClearPoint Prism Neuro Laser Therapy System through our Swedish partner, CLS.
Edit

Stereotactic Neuro-Navigation System Market Analysis Report 2025-2035 | Partnerships and Innovations Drive Progress in Technologies, ...

Nasdaq Globe Newswire 11 Aug 2025
The global stereotactic neuro-navigation system market is anticipated to experience significant growth, escalating from a valuation of $840.7 million in 2024 to $3.10 billion by 2035, with a CAGR of 12.92%.
Edit

Doctors Use Large Neuro Model To Decode Brain Activity

Forbes 10 Aug 2025
A new AI foundation model transforms neurological diagnostics by using data from electrical brain activity to analyze neural patterns ... .
Edit

Tim Scannell, Former Stryker President & COO, Named Chair of Longeviti Neuro Solutions Amid $10M ...

Nasdaq Globe Newswire 08 Aug 2025
Longeviti Neuro Solutions announces Tim Scannell as Chair of its Board and a $10M strategic capital partnership with Soleus Capital ... .
Edit

Neuro-Navigation Systems Market Set To Witness Significant Growth By 2025-2032 Medtronic Plc, Stryker Corporation

MENA FN 08 Aug 2025
(MENAFN - EIN Presswire) Neuro-Navigation Systems Market Insights BURLINGAME, CA, UNITED STATES, August 8, 2025 /EINPresswire / -- Overview. The "Neuro-Navigation Systems Market 2025 Forecast to ... .
Edit

UB Neurosurgery and Ambulatory Neurosurgery Center (ANSC™) in partnership with NOVA Neuro, Awarded First-of-Its-Kind Grant ...

Business Wire 06 Aug 2025
NOVA Neuro, in partnership with UB Neurosurgery, ANSC™, and Prima Mente – a breakthrough precision .
Edit

ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio

ACCESSWIRE 05 Aug 2025
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / August 4, 2025 / ClearPoint Neuro, Inc ... The SmartFlow® Neuro Cannula is the only FDA authorized device indicated for use to administer KEBILIDI ... About the SmartFlow Neuro Cannula ... About ClearPoint Neuro.
Edit

Private Placement (Form 8-K) (Alzamend Neuro Inc)

Public Technologies 01 Aug 2025
) Item 3.02 Unregistered Sales of Equity Securities. Between July 23, 2025 and July 30, 2025, Alzamend Neuro, Inc ... Attachments Original document Permalink. Disclaimer. Alzamend Neuro Inc ... (noodl. 125712741) .
×